Open AccessAPPROACHES TO THE SELECTION OF ANTIFUNGAL THERAPY IN AN HIV-INFECTED PATIENT WITH FLUCONAZOLE-RESISTANT CANDIDIASIS
Author(s) -
Y. S. Filina,
Е. В. Волчкова,
Yuri V. Nesvizhskiy,
O.F. Belaya
Publication year - 2018
Publication title -
èpidemiologiâ i infekcionnye bolezni
Language(s) - English
Resource type - Journals
eISSN - 2411-3026
pISSN - 1560-9529
DOI - 10.18821/1560-9529-2019-23-3-138-141
Subject(s) - fluconazole , antifungal , antifungal drugs , invasive candidiasis , human immunodeficiency virus (hiv) , antiretroviral therapy , candida infections , selection (genetic algorithm) , drug resistance , medicine , biology , intensive care medicine , microbiology and biotechnology , immunology , viral load , artificial intelligence , computer science
Increasing resistance Candida spp. In HIV-infected patients, often receiving long-term antifungal preparations, both for preventive and therapeutic purposes. It is necessary to develop effective treatment regimens based on the study of the resistance of Candida spp. to antifungal drugs, at species and genetic levels.